Biodexa Pharmaceuticals Statistics
Total Valuation
BDRX has a market cap or net worth of $212,127. The enterprise value is -$6.78 million.
Market Cap | 212,127 |
Enterprise Value | -6.78M |
Important Dates
The next estimated earnings date is Tuesday, July 16, 2024, before market open.
Earnings Date | Jul 16, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BDRX has 236,511 shares outstanding. The number of shares has increased by 8,714.17% in one year.
Shares Outstanding | 236,511 |
Shares Change (YoY) | +8,714.17% |
Shares Change (QoQ) | +1,802.61% |
Owned by Insiders (%) | 19.76% |
Owned by Institutions (%) | 22.22% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.44 |
Forward PS | n/a |
PB Ratio | 0.04 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.10.
Current Ratio | 1.26 |
Quick Ratio | 1.19 |
Debt / Equity | 0.10 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -181.56 |
Financial Efficiency
Return on equity (ROE) is -180.60% and return on invested capital (ROIC) is -155.85%.
Return on Equity (ROE) | -180.60% |
Return on Assets (ROA) | -88.10% |
Return on Capital (ROIC) | -155.85% |
Revenue Per Employee | $22,966 |
Profits Per Employee | -$426,703 |
Employee Count | 21 |
Asset Turnover | 0.05 |
Inventory Turnover | n/a |
Taxes
Income Tax | -515,272 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.88% in the last 52 weeks. The beta is 1.47, so BDRX's price volatility has been higher than the market average.
Beta (5Y) | 1.47 |
52-Week Price Change | -82.88% |
50-Day Moving Average | 1.05 |
200-Day Moving Average | 2.20 |
Relative Strength Index (RSI) | 44.82 |
Average Volume (20 Days) | 285,748 |
Short Selling Information
Short Interest | 218,817 |
Short Previous Month | 334,656 |
Short % of Shares Out | 92.52% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, BDRX had revenue of $482,278 and -$8.96 million in losses. Loss per share was -$10.15.
Revenue | 482,278 |
Gross Profit | 483,544 |
Operating Income | -10.17M |
Pretax Income | -9.50M |
Net Income | -8.96M |
EBITDA | -9.09M |
EBIT | -9.45M |
Loss Per Share | -$10.15 |
Balance Sheet
The company has $7.58 million in cash and $588,883 in debt, giving a net cash position of $6.99 million or $29.55 per share.
Cash & Cash Equivalents | 7.58M |
Total Debt | 588,883 |
Net Cash | 6.99M |
Net Cash Per Share | $29.55 |
Equity (Book Value) | 5.94M |
Book Value Per Share | 25.10 |
Working Capital | 1.85M |
Cash Flow
In the last 12 months, operating cash flow was -$9.74 million and capital expenditures -$27,921, giving a free cash flow of -$9.76 million.
Operating Cash Flow | -9.74M |
Capital Expenditures | -27,921 |
Free Cash Flow | -9.76M |
FCF Per Share | -$14.05 |
Margins
Gross margin is 100.26%, with operating and profit margins of -2,108.93% and -1,858.01%.
Gross Margin | 100.26% |
Operating Margin | -2,108.93% |
Pretax Margin | -1,969.72% |
Profit Margin | -1,858.01% |
EBITDA Margin | -1,885.25% |
EBIT Margin | -1,958.93% |
FCF Margin | -2,024.46% |
Dividends & Yields
BDRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8,714.17% |
Shareholder Yield | -8,714.17% |
Earnings Yield | -4,224.24% |
FCF Yield | -4,602.68% |
Analyst Forecast
The average price target for BDRX is $8.00, which is 791.96% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.00 |
Price Target Difference | 791.96% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | -70.02% |
EPS Growth Forecast (5Y) | -67.23% |
Stock Splits
The last stock split was on July 5, 2023. It was a reverse split with a ratio of 1:80.
Last Split Date | Jul 5, 2023 |
Split Type | Reverse |
Split Ratio | 1:80 |
Scores
BDRX has an Altman Z-Score of -21.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -21.34 |
Piotroski F-Score | 2 |